Insider Transaction: Shawn Cavanagh Unloaded 113,749 Shares of Cambrex Corporation (NYSE:CBM)

Share with your friends










Submit

Insider Transaction Shawn Cavanagh Unloaded 113749 Shares of Cambrex Corporation -Transactions

Shawn Cavanagh Insider Sell Transaction

As shown in an electronic document that was filled with the SEC on November 20, 2015, Shawn Cavanagh, EVP & COO of Cambrex Corporation (NYSE:CBM) 50.60 +0.15 0.30% and an insider with a special knowledge about the corporation, sold 113,749 shares of the company for the amount of $5,687,791 USD based on an average share price of $50.0.

Cambrex Corp Stock Rating, Sentiment and Fundamentals

Furthermore, the leading stock analysts of the New Jersey-based company’s financials indicated a predicted earnings for each share of $2.13, according to which Cambrex Corp’s Price/Earnings ratio would be 23.56. Not only that but, an earnings for each share growth rate YOY of 15.00% is expected. It is difficult to make conclusions about Cambrex Corp’s future just from Shawn Cavanagh’s sale because in this filing, the insider also revealed option transactions. In the form, it was reported that Shawn exercised options for 113,749 shares with average price 10.4, worth 1.19 million.

Rating & Sentiment
PsychSignal Social:SELL
Analysts Rating:BUY
Hedge Funds Sentiment:NEUTRAL
Stock Fundamentals
Earnings + FCF Trend:BUY
Sector/Industry Macro:BULLISH
Valuation Models:-
Technical Analysis
ST Trend:UP
MT Trend:UP
LT Trend:UP
OctaFinance Rating*:NEUTRAL

* Read How Our Stock Ratings System Works

The stock price of Cambrex Corp is skyrocketing with no signs of trend change after 67.21 % move in the last 200 days. This uptrend plus Shawn Cavanagh’s insider selling and our trend following system force us to rate the stock “NEUTRAL”. Look at the chart below.

Price Chart of Cambrex Corporation NYSE:CBM Stock

Insider Transaction Shawn Cavanagh Unloaded 113749 Shares of Cambrex Corporation -Stock-Price-Chart

Source: RightEdgeSystems, Yahoo Split & Dividend Adjusted Data and OctaFinance Interpretations

Hedge Funds Ownership

Latest 13F SEC filings disclose 224 institutional investors and hedge funds owned shares of Cambrex Corp. The institutional ownership of Cambrex Corp’s stock in the last quarter is very high, at 89.38 % of the shares outstanding. They increased by 89,884 the total shares they hold. As of that quarter these institutional players and asset managers owned 28.18 million shares. There were 30 funds that closed their positions and 88 that reduced them. A total of 41 funds opened new positions in Cambrex Corp and 71 increased their holdings.

Of them, six have the firm in their Top 10. These funds are: Tfs Capital Llc, Truenorth Inc., Bogle Investment Management L P De, Arbor Capital Management Llc, Thomson Horstmann & Bryant Inc, Weber Alan W.

HEDGE-FUNDS-LIST-DATABASE-FREE

Tfs Capital Llc had the greatest investment with ownership of 200,517 shares as of Q2 2015 for 0.86% of the fund’s portfolio. Truenorth Inc. is another bullish asset manager owning 117,479 shares of the company or 2.46% of their stocks portfolio. The stock is also 1.27% of the fund’s AUM. In addition Bogle Investment Management L P De have 1.01% of their stock portfolio invested in the company’s market cap for 307,826 shares. The Minnesota-based fund Arbor Capital Management Llc disclosed it had acquired a stake worth 1.45% of the fund’s stock portfolio in Cambrex Corp. Thomson Horstmann & Bryant Inc is also positive about the firm, owning 365,096 shares or 1.22% of their stock portfolio.

Cambrex Corporation NYSE:CBM Company Profile

Cambrex Corporation (Cambrex) is a life sciences company that provides products and services for the development and commercialization of new and generic therapeutics. The Company supplies its products and services worldwide to innovator and generic pharmaceutical companies. The Company’s customers include generic drug companies and companies that discover and commercialize small molecule human therapeutics using organic chemistry. Its business consists of the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. The Company’s products include active pharmaceutical ingredients (APIs), pharmaceutical intermediates and, to a lesser extent, other fine chemicals. Cambrex has three operating segments, which are manufacturing facilities that have been aggregated as one reportable segment.

Company Website: Cambrex Corporation

The company has 1117 employees. Currently its market worth is: $1.58 billion and it has 32.26 million outstanding shares. Now the company has 97.90% shareholders and the institutional ownership is 97.90%. Cambrex Corp was filled in Delaware on 1983-10-11. The stock closed at $50.18 yesterday and it had average 2 days volume of 54771 shares. It is down from the 30 days average shares volume of 83571. Cambrex Corp has a 52weeks low of $21.14 and a 52w high of $54.52. The current price is above the 200 days SMA. Cambrex Corp last issued its quarterly earnings data on 11/03/2015. The company reported 0.36 EPS for the quarter, above the consensus estimate of 0.34 by 0.02. The company had a revenue of 92.98 million for 9/30/2015 and 106.64 million for 6/30/2015. Therefore, the revenue was -13,656,000 down.

* The option representing a right to purchase 75 – 000 shares became exercisable in four equal installments beginning on January 27 – 2012 – which was the first anniversary of the date on which the option was granted.

* The option representing a right to purchase 35 – 000 shares became exercisable in four equal installments beginning on October 18 – 2012 – which was the first anniversary of the date on which the option was granted.

* The option representing a right to purchase 40 – 000 shares became exercisable in four equal installments beginning on October 24 – 2013 – which was the first anniversary of the date on which the option was granted.

* The option representing a right to purchase 40 – 000 shares became exercisable in four equal installments beginning on October 28 – 2014 – which was the first anniversary of the date on which the option was granted.

* The option representing a right to purchase 40 – 000 shares became exercisable in four equal installments beginning on October 22 – 2015 – which was the first anniversary of the date on which the option was granted.

Cambrex Corporation - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.